Y. Luo et al. / Tetrahedron: Asymmetry 15 (2004) 17–19
19
1
11. Analytical data for 5a, 5b, 7a, 7b. 5a: H NMR (d, ppm;
CDCl3): 8.18 (dd, 1H, J ¼ 8:4, 2.1 Hz), 7.92 (d, 1H,
J ¼ 8:1 Hz), 7.83 (dd, 1H, J ¼ 11:4, 8.4 Hz), 7.77–7.72 (m,
2H), 7.56–7.11 (m, 16H), 6.96 (d, 1H, J ¼ 8:7 Hz), 2.86 (d,
1H, J ¼ 15:0 Hz), 2.46 (d, 1H, J ¼ 15:0 Hz), 2.28–2.19 (m,
1H), 2.04–1.94 (m, 2H), 1.24 (d, 2H, J ¼ 9:0 Hz), 0.80 (s,
Ester 7 was also separated into 7a and 7b by chroma-
tography on silica gel with Et2O as eluent. Both 7a and
7b serve as key intermediates in monophosphine syn-
thesis.11
In summary, we have provided a novel method for
preparing chiral MOPs. This method involves the simple
resolution of hydroxy monophosphines or their oxides
bearing a naphthalene moiety. The enantiomerically
pure form of 4 and 6 can allow the rapid construction
of a series of chiral monophosphine ligands.
3H), 0.57 (s, 3H); 13C NMR (d, ppm;CDCl ): camphor:
3
213.2, 57.6, 48.9, 47.4, 42.6, 42.1, 26.6, 24.9, 19.4, 19.3,
aryl: 146.0–119.9; 31P NMR (d, ppm;CDCl 3): 29.4;IR
(KBr;wavenumber, cm À1): 3056 (m), 2959 (s), 1746 (vs),
1591 (m), 1509 (m), 1437 (s), 1371 (vs), 1198 (vs), 1168
(vs), 1116 (s), 964 (s), 941 (s), 819 (vs), 749 (s), 699 (vs), 539
(s), 524 (s);MS (ESI): m=z 685.2 [M+1], 686.2 [M+2],
707.1 [M+1]Na, 708.1 [M+2]Na;HRMS m=z calcd for
C42H38O5SP [M+1]þ: 685.2174, found: 685.2172;De: 98%.
5b: 1H NMR (d, ppm;CDCl 3): 8.16 (dd, 1H, J ¼ 8:4,
2.1 Hz), 7.92 (d, 1H, J ¼ 8:1 Hz), 7.84 (dd, 1H, J ¼ 11:4,
8.4 Hz), 7.77–7.72 (m, 2H), 7.56–7.13 (m, 16H), 6.96 (d,
1H, J ¼ 8:4 Hz), 3.1 (d, 1H, J ¼ 15:0 Hz), 2.25–2.16 (m,
1H), 2.08 (d, 1H, J ¼ 15:0 Hz), 1.97–1.88 (m, 2H), 1.82–
1.75 (m, 2H), 1.37–1.20 (m, 2H), 0.68 (s, 3H), 0.41 (s, 3H);
13C NMR (d, ppm;CDCl 3): camphor: 213.4, 57.4, 48.8,
47.4, 42.4, 42.1, 26.6, 24.3, 19.2, 19.0, aryl: 145.7–120.2;
Acknowledgements
We thank the National Natural Science Foundation of
China and the Chinese Academy of Sciences for finan-
cial support.
31P NMR (d, ppm;CDCl ): 29.4;IR (KBr;wavenumber,
References and Notes
3
cmÀ1): 3055 (m), 2959 (s), 1747 (vs), 1591 (m), 1509 (m),
1437 (s), 1362 (vs), 1199 (s), 1168 (vs), 1116 (s), 965 (s), 941
(s), 817 (vs), 749 (s), 699 (vs), 539 (s), 524 (s);MS (ESI):
m=z 685.2 [M+1], 686.2 [M+2], 707.1 [M+1]Na, 708.1
[M+2]Na;HRMS m=z calcd for C42H38O5 SP [M+1]þ:
685.2174, found: 685.2172;De: 95%. 7a: 1H NMR (d,
ppm;CDCl 3): 8.02 (dd, 1H, J ¼ 9:0, 2.1 Hz), 7.94–7.87 (m,
2H), 7.74 (dd, 2H, J ¼ 11:1, 8.7 Hz), 7.52 (dd, 2H, J ¼ 6:9,
8.7 Hz), 7.38–7.25 (m, 7H), 7.17–7.11 (m, 2H), 7.01–6.94
(m, 2H), 6.89 (dd, 2H, J ¼ 7:8, 2.4 Hz), 2.82 (d, 1H,
J ¼ 15:0 Hz), 2.4 (d, 1H, J ¼ 15:0 Hz);2.87 (s, 3H), 2.25
(s, 3.5H), 2.22–2.19 (m, 0.5H), 2.04–1.76 (m, 4H), 1.26–
1.23 (m, 2H), 0.80 (s, 3H), 0.56 (s, 3H); 13C NMR (d, ppm;
CDCl3): 213.2, 57.6, 48.9, 47.4, 42.6, 42.2, 26.6, 25.0,
21.41, 21.40, 21.37, 21.36, 19.5, and 19.3, aryl: 146.0–
120.0; 31P NMR (d, ppm;CDCl 3): 29.8. IR (KBr;
wavenumber, cmÀ1): 2958 (m), 1748 (vs), 1601 (m), 1369
(vs), 1216 (s), 1197 (s), 1168 (vs), 1114 (s), 965 (s), 941 (s),
810 (vs), 749 (s), 681 (s), 659 (s), 526 (vs);MS (ESI): m=z
713.2 [M+1];714.2 [M+2];735.2 [M+1]Na. HRMS calcd
for C44H41O5SPNa [M+1]Naþ: 735.2341, found: 735.2304.
De: 97%. 7b: 1H NMR (d, ppm;CDCl 3): 8.00 (dd, 1H,
J ¼ 8:7, 2.1 Hz), 7.95–7.90 (m, 2H), 7.73 (dd, 2H,
J ¼ 11:1, 8.4 Hz), 7.52–7.45 (m, 2H), 7.38–7.24 (m, 6H),
7.15–7.12 (m, 2H), 7.03 (dd, 2H, J ¼ 8:1, 2.4 Hz), 6.96 (d,
1H, J ¼ 13:8 Hz), 6.90 (dd, 2H, J ¼ 7:8, 2.4 Hz), 3.08 (d,
1H, J ¼ 15:0 Hz), 2.3 (s, 3H), 2.26 (s, 3.5H), 2.19–2.18 (m,
0.5H), 2.06 (d, 1H, J ¼ 15:0 Hz), 2.00–1.76 (m, 4H), 1.34–
1.25 (m, 2H), 0.67 (s, 3H), 0.40 (s, 3H); 13C NMR (d, ppm;
CDCl3): Camphor: 213.3, 57.4, 48.8, 47.4, 42.36, 42.1,
26.6, 24.3, 21.43, 21.41, 21.38, 21.36, 19.2, 19.0, aryl:
1. Kurz, L.;Lee, G.;Morgans, D.;Waldyke, J. M. J.;Ward,
D. Tetrahedron Lett. 1990, 31, 6321–6324.
2. Uozumi, Y.;Tanahashi, A.;Lee, S.-Y.;Hayashi, T.
J. Org. Chem. 1993, 58, 1945–1948.
3. (a) Uozumi, Y.;Hayashi, T. J. Am. Chem. Soc. 1991, 113,
9887–9888;(b) Hayashi, T.;Uozumi, Y. Pure Appl. Chem.
1992, 60, 1911–1916;(c) Uozumi, Y.;Lee, S.-Y.;Hayashi,
T. Tetrahedron Lett. 1992, 33, 7185–7188;(d) Uozumi, Y.;
Hayashi, T. Tetrahedron Lett. 1993, 34, 2335–2338;(e)
Uozumi, Y.;Kitayama, K.;Hayashi, T.
Asymmetry 1993, 4, 2419–2422.
Tetrahedron:
4. Matsumoto, Y.;Naito, M.;Uozumi, Y.;Hayashi, T.
Chem. Soc., Chem. Commun. 1993, 1468–1469.
5. Hayashi, T.;Iwamura, H.;Naito, M.;Matsumoto, Y.;
Uozumi, Y.;Miki, M.;Yanagi, K. J. Am. Chem. Soc.
1994, 116, 775–776.
6. (a) Kodama, H.;Taiji, T.;Ohta, T.;Furukawa, I.
Tetrahedron: Asymmetry 2000, 11, 4009–4015;(b) Uoz-
umi, Y.;Suzuki, N.;Ogiwara, A.;Hayashi, T. Tetrahedron
1994, 50, 4293–4302.
J.
7. (a) Sakai, N.;Mano, S.;Nozaki, K.;Takaya, H.
J. Am.
Chem. Soc. 1993, 115, 7033–7034;(b) Nozaki, K.;Li, W.;
Horiuchi, T.;Takaya, H. J. Org. Chem. 1996, 61, 7658–
7659;(c) Horiachi, T.;Ohata, T.;Shirakawa, E.;Nozaki,
K.;Takaya, H. J. Org. Chem. 1997, 62, 4285–4292;(d)
Nozaki, K.;Sakai, N.;Nanno, T.;Higashijima, T.;Mano,
S.;Horiachi, T.;Takaya, H. J. Am. Chem. Soc. 1997, 119,
4413–4423.
8. (a) Gladiali, S.;Dore, A.;Fabbri, D.
Tetrahedron:
Asymmetry 1994, 5, 1143–1146;(b) Gladiali, S.;Medici,
S.;Pirri, G.;Pulacchini, S.;Fabbri, D. Can. J. Chem. 2001,
79, 670–678.
141.5–120.3; 31P NMR (d, ppm;CDCl ): 29.8;IR (KBr;
3
wave number, cmÀ1): 2958 (m), 1748 (vs), 1601 (m), 1362
(vs), 1216 (s), 1197 (s), 1167 (vs), 1114 (s), 965 (s), 941 (s),
811 (vs), 774 (s), 749 (s), 681 (s), 660 (s), 526 (vs);MS (ESI)
m=z 713.2 [M+1], 714.2 [M+2], 715.2 [M+3], 735.2
9. Hattori, I.;Sakamoto, J.;Hayshizaka, N.;Miyano, S.
Synthesis 1994, 199–202.
10. Kadyrov, R.;Heinicke, J.;Kinderman, M. K.;Heller, D.;
Fischer, C.;Selke, R.;Fischer, A. K.;Jones, P. G. Chem.
Ber. 1997, 130, 1663–1670.
[M+1]Na;HRMS
m=z calcd for C44H41O5SPNa
[M+1]Naþ: 735.2328, found: 735.2304;De: 99%.